Physician profile
Janice Barr
NPI 1649246158
$3,229.30
in general payments reported to CMS, 2019-2025
17 companies · $496 in 2025
The $496 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $116 · 2021: $218 · 2022: $175 · 2023: $801 · 2024: $745 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,942 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,942.43 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $495.47 | 2023-2025 | Acthar |
| Abbvie INC. | $350.31 | 2023-2025 | Vuity |
| Glaukos Corporation | $265.48 | 2023-2024 | Ce-Marked Kxla System |
| Johnson & Johnson Vision Care, INC. | $261.68 | 2019 | |
| Dompe US, INC. | $249.83 | 2024-2025 | Oxervate |
| Alcon Vision LLC | $223.40 | 2021-2024 | Total30, Dailies Total1, Precision 1 |
| Allergan, INC. | $209.97 | 2021-2022 | |
| Shire North American Group INC | $190.30 | 2019 | |
| Eyepoint US, INC. | $135.71 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $126.81 | 2019 | |
| Bausch & Lomb Americas INC. | $124.98 | 2024 | Xiidra, Miebo |
| Sun Pharmaceutical Industries INC. | $124.56 | 2025 | |
| Genentech USA, INC. | $116.00 | 2020 | |
| Apellis Pharmaceuticals, INC. | $101.39 | 2023 | Syfovre |
| Carl Zeiss Meditec, INC. | $99.27 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $78.01 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $76.13 | 2023 | Tecnis Iol, Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.